PCM
RGLS

Piermont Capital Management’s Regulus Therapeutics RGLS Stock Holding History

Piermont Capital Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,384
Closed -$548K – 272
2016
Q3 		$548K Buy
1,384
+118
+9% +$46.7K 0.13% 228
2016
Q2 		$439K Buy
+1,266
New +$439K 0.11% 231